Pancreatic Cancer Research

ResearcherNew York UniversityActive in the last 2 years

John W. Kunstman

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2618-4173; OpenAlex author ID A5072116736. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
81
Papers, trials and grants by year

2020: 1 paper · 2021: 3 papers · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: none · 2026: 4 papers

Papers 10

  1. SPINK1-COL18A1 crosstalk shapes epigenome and drives cancer stemness in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.celrep.2026.117806↗
  2. Frailty and home time loss after surgical resection for patients with non-metastatic pancreatic cancer. Last author DOI 10.1016/j.jgo.2026.104663↗
  3. Frailty and low utilization of curative-intent surgical resection in nonmetastatic pancreatic cancer. Last author DOI 10.1093/jncics/pkag078↗
  4. Pancreatic Adenocarcinoma, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology. Co-author DOI 10.6004/jnccn.2026.0046↗
  5. Perioperative Modified FOLFIRINOX for Resectable Pancreatic Cancer: A Nonrandomized Controlled Trial. Co-author DOI 10.1001/jamaoncol.2024.1575↗
  6. Change in Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Treatment Does Not Predict Pathological Response and Survival in Resectable Pancreatic Ductal Adeno… Co-author DOI 10.1177/0003134821989050↗
  7. Methylation-based Cell-free DNA Signature for Early Detection of Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000001919↗
  8. Renalase is a novel tissue and serological biomarker in pancreatic ductal adenocarcinoma. Co-author DOI 10.1371/journal.pone.0250539↗
  9. Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. Co-author DOI 10.6004/jnccn.2021.0017↗
  10. Association of Treatment Inequity and Ancestry With Pancreatic Ductal Adenocarcinoma Survival. Last author DOI 10.1001/jamasurg.2019.5047↗

Closest collaborators

The 25 strongest of 81 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lauren Raymond-King · 2 shared papers, 2026 · strength 0.59
  2. Bhramar Mukherjee · 2 shared papers, 2026 · strength 0.59
  3. Nita Ahuja · 3 shared papers, 2020–2026 · strength 0.47
  4. Ankit Chhoda · 2 shared papers, 2021–2026 · strength 0.32
  5. Laura DeLong Wood · 2 shared papers, 2021–2026 · strength 0.32
  6. Christopher Lee Wolfgang · 2 shared papers, 2021–2026 · strength 0.32
  7. Christine A. Iacobuzio–Donahue · 2 shared papers, 2021–2026 · strength 0.32
  8. Timothy R. Donahue · 2 shared papers, 2021–2026 · strength 0.27
  9. Andrew H. Ko · 2 shared papers, 2021–2026 · strength 0.27
  10. Charles M. Vollmer · 2 shared papers, 2021–2026 · strength 0.27
  11. Brian G. Czito · 2 shared papers, 2021–2026 · strength 0.27
  12. Marsha Reyngold · 2 shared papers, 2021–2026 · strength 0.27
  13. Patricio Marcelo Polanco · 2 shared papers, 2021–2026 · strength 0.27
  14. Noelle K. LoConte · 2 shared papers, 2021–2026 · strength 0.27
  15. Robert A. Wolff · 2 shared papers, 2021–2026 · strength 0.27
  16. Courtney L. Scaife · 2 shared papers, 2021–2026 · strength 0.27
  17. Eric K. Nakakura · 2 shared papers, 2021–2026 · strength 0.27
  18. Mokenge Peter Malafa · 2 shared papers, 2021–2026 · strength 0.27
  19. Jeffrey M. Hardacre · 2 shared papers, 2021–2026 · strength 0.27
  20. Brian Matthew Wolpin · 2 shared papers, 2021–2026 · strength 0.27
  21. Dana Backlund Cardin · 2 shared papers, 2021–2026 · strength 0.27
  22. Mary E. Dillhoff · 2 shared papers, 2021–2026 · strength 0.27
  23. Andrew M. Lowy · 2 shared papers, 2021–2026 · strength 0.27
  24. Vincent M. Chung · 2 shared papers, 2021–2026 · strength 0.27
  25. Christos K Fountzilas · 2 shared papers, 2021–2026 · strength 0.27

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.